Results 111 to 120 of about 48,929 (237)

Three-Year Outcomes, Risk Factors for Restenosis After Stenting for DVT Combined with Iliac Vein Compression Syndrome

open access: yesClinical and Applied Thrombosis/Hemostasis
This study aimed to evaluate the safety and efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) and stenting for treating acute iliofemoral deep venous thrombosis (DVT) combined with iliac vein compression syndrome (IVCS), and to ...
Lin Zhang MM   +5 more
doaj   +1 more source

Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study

open access: yesPortal Hypertension &Cirrhosis, Volume 5, Issue 2, Page 160-169, June 2026.
CN‐TIPS is a nationwide, multicenter prospective registry that will enroll 10,000 adults with portal hypertension undergoing transjugular intrahepatic portosystemic shunt in China, integrating perioperative clinical and hemodynamic metrics with standardized imaging (including computational modeling in a dedicated subcohort) and multi‐omics biospecimens,
Yi Xiang   +20 more
wiley   +1 more source

Fractional flow reserve versus intravascular ultrasound guidance for percutaneous coronary intervention in intermediate coronary stenoses: A systematic review and meta‐analysis

open access: yesPrecision Medical Sciences, Volume 15, Issue 2, Page 102-112, June 2026.
Fractional Flow Reserve versus Intravascular Ultrasound for guiding percutaneous coronary intervention in coronary artery disease: A systematic review and meta‐analysis of 5 studies (over 3,900 patients) showing comparable outcomes in MACE, mortality, and target vessel revascularization.
Sanket Patel   +13 more
wiley   +1 more source

Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies

open access: yesEuropean Journal of Case Reports in Internal Medicine
Intracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli   +5 more
doaj   +1 more source

Marked Respiratory Improvement After ECMO‐Supported Exchange From Metallic to Silicone Stent in Tracheobronchial Stenosis due to Tuberculosis: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 6, June 2026.
This report highlighted the importance of silicone stents in the management of benign airway stenosis. ABSTRACT A woman in her mid‐50s with tracheobronchial stenosis due to tuberculosis underwent covered metallic stent insertion via flexible bronchoscopy at a referral hospital.
Mayu Goda   +16 more
wiley   +1 more source

A Multicenter Prospective Study on the Safety and Efficacy of the New Low Axial Force Self‐Expandable Metallic Stent With Slim Delivery System for Malignant Colorectal Obstruction

open access: yesDigestive Endoscopy, Volume 38, Issue 6, June 2026.
This new low‐AF stent with 9Fr delivery system is highly safe and effective, demonstrating high technical and clinical success rates for placement and a low incidence of adverse events. ABSTRACT Objectives Self‐expandable metallic stents are widely used for malignant colorectal obstruction, and low axial force (AF) stents have been developed to reduce ...
Takeshi Mizumoto   +13 more
wiley   +1 more source

Restenosis risk factors after coronary stenting in metabolic syndrome patients

open access: yesКардиоваскулярная терапия и профилактика, 2007
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus.
N. M. Danilov   +3 more
doaj  

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

open access: yesJournal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan   +3 more
doaj   +1 more source

Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1

open access: yesJournal of Materials Science: Materials in Medicine
In-stent restenosis (ISR) following interventional therapy is a fatal clinical complication. Current evidence indicates that neointimal hyperplasia driven by uncontrolled proliferation of vascular smooth muscle cells (VSMC) is a major cause of restenosis.
Jiabing Huang   +4 more
doaj   +1 more source

Assessment of Plaque Characteristics by Contrast-Enhanced Ultrasound and Stent Restenosis following Carotid Artery Stenting: A Retrospective Study

open access: yesMedicina
Background and objective: carotid artery stenosis contributes significantly to ischemic strokes, with management options including carotid endarterectomy (CEA) and carotid artery stenting (CAS) ischemic stroke risk can be reduced.
Agnė Gimžauskaitė   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy